Tuesday, November 20, 2012 10:51:22 PM
[i]“I believe in MANF,” said Dr. Rubinfeld, “I have reviewed a great number of technologies in my 45 year career in the biopharmaceutical field, and I believe that MANF could be one of the biggest successes that I have ever seen.
“Clearly, Dr. Rubinfeld joining the Advisory Board is a tremendous endorsement for the Company at this critical juncture in our growth cycle,” said Gerald E. Commissiong, President & CEO of Amarantus.
http://www.amarantus.com/wp-content/uploads/2012/11/121106-PR-AMBS-Rubinfeld-FINAL.pdf
Folks, AMBS is not your regular stinky pinky. It might resemble a P&D right now because of daytraders/flippers but make no mistake, AMBS is for REAL. Would a respected and dignified person such as Dr. Rubinfeld endorse and be a part of a fraudulent sham? NO WAY!
AMBS a fully reporting Nasdaq OTCQB top tier penny stock at the highest level, just below the big boards. IMO, This one is an investment and Longs will very soon reap their rewards...
FEATURED Are we about to see a comeback? Steakholder Foods Charges Forward with New Commitments from Multiple International Players as it Transitions to Revenue Generation • Nov 18, 2024 11:56 AM
FEATURED North Bay Resources Announces Production of Gold Concentrate and Refinery Shipment at Bishop Gold Mill, California • Nov 18, 2024 9:00 AM
One World Products Sets New Standards in Sustainability With Strategic Hemp Innovations • OWPC • Nov 18, 2024 7:54 AM
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM